Polysomnography (Sleep Study) Interpretation by Decade of Life

What Polysomnography Measures and Why Age Changes Everything

A standard in-lab PSG records electroencephalography (EEG), electrooculography (EOG), chin electromyography (EMG), respiratory airflow, respiratory effort, oxygen saturation, leg movements, and cardiac rhythm simultaneously across a single night. The result is a multi-channel record that trained sleep physicians score into sleep stages and respiratory events using the American Academy of Sleep Medicine (AASM) 2020 scoring rules.

Age changes every single one of those outputs. The AASM states in its clinical practice guidelines that "normative values for PSG parameters differ substantially across the lifespan," and the largest normative dataset to date, the Study of Osteoporotic Fractures (N=2,685 community-dwelling adults aged 55-99), demonstrated that AHI, arousal index, and sleep efficiency all shift in a dose-response fashion with advancing decade. [1]

The Core Metrics Scored on Every PSG

Apnea-Hypopnea Index (AHI). Total apneas plus hypopneas divided by total sleep time in hours. This is the primary diagnostic metric for obstructive sleep apnea (OSA).

Sleep architecture percentages. The proportion of total sleep time spent in N1 (light), N2 (intermediate), N3 (slow-wave / deep), and REM. N3 and REM carry the largest physiological stakes for hormone secretion and memory consolidation.

Sleep efficiency. Total sleep time divided by total time in bed, expressed as a percentage. A value below 85% in an adult under 60 generally prompts clinical attention.

Arousal index. Number of EEG arousals per hour of sleep. Values above 10-15 per hour in mid-life adults associate with impaired cognitive performance and blunted overnight growth hormone pulses. [2]

Oxygen desaturation index (ODI). Number of times per hour that SpO2 drops 4% or more below baseline. An ODI above 5 mirrors AHI for OSA severity classification in most lab protocols. [3]

OSA Thresholds: The AHI Cut-Points That Drive Treatment Decisions

An AHI below 5 events per hour is universally classified as normal in adults. An AHI of 5-14.9 is mild OSA, 15-29.9 is moderate, and 30 or above is severe. These cut-points come from the International Classification of Sleep Disorders, Third Edition (ICSD-3) and are endorsed by the AASM. [4]

Why the Same AHI Means Different Things at Different Ages

A 2013 meta-analysis published in PLOS ONE (N=11 cohort studies, total N greater than 24,000 participants) found that OSA prevalence by AHI threshold of 5 or higher rises from roughly 14% in adults aged 30-49 to approximately 49% in men aged 50-70 and 23% in women aged 50-70. [5] The biology is straightforward: upper airway muscle tone declines, adipose tissue redistributes, and post-menopausal women lose the progesterone-mediated respiratory drive that partly protected them before menopause.

The Testosterone-OSA Feedback Loop

Untreated moderate-to-severe OSA suppresses overnight luteinizing hormone (LH) pulsatility, which in turn lowers morning testosterone. A 2012 study in The Journal of Clinical Endocrinology and Metabolism showed that men with AHI of 30 or higher had mean free testosterone levels 21% lower than age-matched controls without OSA, independent of BMI. [6] This connection is why HealthRX evaluates PSG data alongside testosterone panels before initiating TRT. Treating OSA first can raise testosterone by 2-4 nmol/L in some men without any exogenous hormone.

Sleep Architecture by Decade: The Normal Ranges Clinicians Use

Sleep architecture changes are the least appreciated finding in PSG reports handed to patients. Labs often mark everything "within normal limits for age" without specifying what that means. The table below synthesizes normative data from the Wisconsin Sleep Cohort, the Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Study, and the AASM normative review. [1][7][8]

Ages 20-29: The Baseline Decade

In healthy adults in their 20s, N3 slow-wave sleep occupies 15-25% of total sleep time, REM sits at 20-25%, N2 at 45-55%, and N1 below 10%. Sleep efficiency typically exceeds 93%. Arousal index is normally below 10 per hour. AHI above 5 at this age is uncommon (prevalence approximately 6-10%) and should trigger a full OSA work-up rather than a "normal for age" dismissal.

Ages 30-39: The First Architecture Shift

N3 begins declining in the early 30s, particularly in men. By age 39, many men have N3 percentages in the 12-18% range while women of the same age often retain 18-22%. The Wisconsin Sleep Cohort (N=1,522) documented this sex divergence clearly. [7] Sleep efficiency remains above 90% in most healthy adults in this decade. An AHI above 5 warrants attention; above 10 in a 30-something should prompt treatment given the decades of cardiovascular exposure ahead.

Ages 40-49: Where OSA Prevalence Accelerates

OSA prevalence more than doubles between the 30s and 40s in men. The MESA Sleep Study (N=2,237 adults, mean age 68) established that apnea events increase by roughly 10% per decade of chronological age in men. [8] In the 40s, N3 often falls to 10-15% in men. Perimenopause in women commonly begins in the mid-40s, and with it comes an early loss of progesterone-driven respiratory protection, raising female OSA prevalence from under 6% to approximately 10-12% by age 49.

Sleep efficiency in healthy 40-somethings still holds at 87-93%. A drop below 85% deserves investigation for pain, anxiety, restless legs syndrome, or early sleep apnea.

Ages 50-59: Menopause Convergence and Deep Sleep Loss

Post-menopausal women show PSG profiles that converge toward male norms by the mid-50s. A 2003 SLEEP journal study (N=589 women, ages 48-67) found that post-menopausal women off hormone therapy had AHI values 3.5 times higher than pre-menopausal women of similar BMI. [9] Estradiol and progesterone replacement partially restores the respiratory drive advantage, an important clinical consideration in HRT candidate evaluation.

N3 in this decade typically falls to 8-14% in men and 10-16% in women. REM holds relatively well at 18-22% if OSA is absent, but even mild OSA (AHI 5-15) preferentially fragments REM and N3, which are the stages most associated with growth hormone release and testosterone pulses overnight.

Ages 60-69: The New Normal Requires Different Thresholds

In community-dwelling adults in their 60s, mean AHI values of 10-20 per hour are common. The Study of Osteoporotic Fractures reported a median AHI of 16.4 in women aged 67-96. [1] This does not mean AHI of 16 is "fine" in a 65-year-old. It means treatment decisions must integrate symptoms, oxygen desaturation, and cardiovascular risk rather than the AHI number alone.

AASM guidelines still recommend CPAP evaluation for AHI of 15 or higher regardless of symptoms, or AHI of 5 or higher in the presence of daytime sleepiness, hypertension, or cardiovascular disease. [4]

N3 in healthy 60-somethings often falls to 5-10%. Sleep efficiency targets shift to 80-85% as acceptable, reflecting the documented increase in WASO (wake after sleep onset). A WASO above 60 minutes in this decade is considered clinically elevated and associated with increased all-cause mortality in the cardiovascular literature. [10]

Ages 70 and Older: Distinguishing Normal Aging from Pathology

By the 70s, N3 may account for only 3-8% of total sleep time. REM may compress to 15-18%. Sleep efficiency of 78-82% is common. The challenge in this decade is separating age-related architecture change from treatable disorders like REM sleep behavior disorder (RBD), central sleep apnea, or periodic limb movement disorder (PLMD).

RBD, characterized by loss of REM atonia and acting out dreams, has a prevalence of 1.06% in adults over 60 per a 2018 JAMA Neurology study (N=19,940 adults). [11] It is a prodromal marker for synucleinopathies including Parkinson's disease and Lewy body dementia, making accurate PSG interpretation in the 70-plus age group a potential early-detection opportunity.

Oxygen Saturation and Desaturation: The Cardiovascular Stake

Baseline SpO2 during sleep should remain above 94% throughout the night in healthy adults. The oxygen desaturation index (ODI) parallels AHI in most cases but captures a slightly different physiological burden: the cumulative dose of intermittent hypoxemia the cardiovascular system absorbs each night.

T90: The Longevity Metric Labs Often Under-Report

T90, the percentage of total sleep time spent with SpO2 below 90%, is a more granular severity marker than AHI alone. A T90 above 1% in an adult under 60 is clinically significant. A T90 above 10% at any age is associated with a roughly 2.2-fold increase in cardiovascular mortality in data from the Sleep Heart Health Study (N=6,441). [12]

Many commercial sleep labs report T90 only in the "additional data" section of a PSG report, below the fold. If your report does not show T90, ask the interpreting physician to locate it before closing the chart.

ODI by Age: Expected Ranges

ODI in adults aged 20-40 without OSA should be below 5. In adults aged 41-60, community values cluster in the 3-8 range with no symptoms; above 10 warrants formal OSA classification. In adults 61 and older, an ODI up to 10 may be observed without discrete apneas, reflecting age-related blunting of arousal thresholds, but ODI above 15 should still trigger CPAP consideration given the cardiovascular evidence. [3]

Arousal Index and Its Hormone Consequences

The arousal index, meaning EEG-defined cortical arousals per hour, is normal below 10-15 in adults aged 20-50 and below 15-20 in adults aged 51-70. Elevated arousal indices fragment slow-wave sleep, which is when 70-80% of daily growth hormone secretion occurs per the neuroendocrine literature. [2]

Cortisol, GH, and the N3 Connection

Each arousal from N3 triggers a micro-burst of cortisol and terminates the ongoing growth hormone (GH) pulse. In a controlled crossover study, selective N3 suppression by acoustic stimulation (without changing total sleep time) reduced overnight GH secretion by 23% and raised morning cortisol by 8% after just three nights. [2] For patients in a TRT or peptide program, a high arousal index on PSG is often the hidden variable suppressing the endogenous anabolic milieu that the treatment is trying to restore.

How PSG Results Guide Hormone Optimization Decisions

The HealthRX clinical protocol treats PSG as a required context layer before finalizing hormone dosing decisions in any patient with: morning testosterone below 400 ng/dL, Epworth Sleepiness Scale score of 10 or higher, BMI <27 with unexplained fatigue, or perimenopausal/post-menopausal women reporting non-restorative sleep despite HRT.

When PSG Should Precede TRT Initiation

Exogenous testosterone at supraphysiological levels can worsen upper airway obstruction by increasing tongue base volume and shifting ventilatory control. The Endocrine Society's 2018 clinical practice guideline on male hypogonadism states: "We suggest against initiating testosterone therapy in patients with untreated severe obstructive sleep apnea." [13] An AHI of 30 or higher is the threshold that triggers mandatory pre-treatment CPAP stabilization at HealthRX.

PSG Timing in the HRT Work-Up for Women

Progesterone has direct respiratory stimulant effects via medullary progesterone receptors. Post-menopausal women starting oral micronized progesterone (OMP) at 100-200 mg nightly often show AHI reductions of 20-30% on repeat PSG. A 2014 Menopause journal pilot study (N=21 post-menopausal women) reported a mean AHI reduction from 19.8 to 13.4 events per hour after 3 months of OMP, statistically significant at P<0.05. [14] This means a baseline PSG before HRT start and a repeat study at 90 days can objectively quantify the respiratory benefit of progesterone repletion.

Home Sleep Apnea Testing vs. Full In-Lab PSG: When Each Is Appropriate

Home sleep apnea tests (HSAT) record only 3-4 channels (airflow, respiratory effort, SpO2, pulse rate) and lack EEG. They cannot score sleep stages, calculate accurate sleep efficiency, or detect PLMD or RBD.

AASM recommends full in-lab PSG over HSAT when any of the following apply: [4]

• Moderate-to-severe comorbid insomnia is present alongside suspected OSA
• Neuromuscular disease, heart failure, or chronic opioid use
• Prior inconclusive HSAT
• Suspected central sleep apnea, RBD, or PLMD
• Age 65 or older with complex symptom picture

For straightforward OSA screening in a healthy adult aged 30-60, HSAT with a qualified sleep physician to interpret results is a reasonable first step. HSAT systematically underestimates AHI by 10-20% compared to full PSG because it divides respiratory events by recording time rather than confirmed sleep time. [4] A "normal" HSAT AHI of 4.3 may translate to a true PSG AHI of 5.2 in the same patient, which crosses the clinical threshold.

Periodic Limb Movements: The PSG Finding Clinicians Often Miss

Periodic limb movement disorder (PLMD) is defined by a periodic limb movement index (PLMI) above 15 per hour in adults with associated sleep complaints. The PLMI increases with age: mean values in adults aged 60-69 reach 20-25 per hour in some cohort data. [15] PLMD directly fragments N3 and elevates the arousal index even when OSA is absent, which creates the same downstream hormone consequences described above.

Ferritin below 50 mcg/L is the most modifiable risk factor for restless legs syndrome and PLMD. Iron replacement to ferritin above 75 mcg/L reduces PLMI by approximately 30% in iron-deficient adults per a Cochrane review published in 2019. [15]

Interpreting Your PSG Report: A Practical Checklist

When a PSG report arrives, check these values in order before accepting a summary interpretation:

1. AHI: Is it below 5? If not, what severity category?
2. RDI (respiratory disturbance index): Some labs use RDI, which includes RERA (respiratory effort-related arousals). RDI above 10 with AHI below 5 still carries clinical weight.
3. N3 percentage: Compare to the decade-specific ranges above.
4. REM percentage: Below 15% is a red flag at any age.
5. Sleep efficiency: Apply the age-appropriate threshold.
6. Arousal index: Above 15 in adults under 60 deserves an explanation.
7. T90: Request this number if it is not on the front page.
8. PLMI: Above 15 with symptoms meets PLMD criteria.
9. Minimum SpO2: Below 85% at any point is a severe hypoxemia event.
10. Epworth Sleepiness Scale score documented alongside the PSG: Objective severity without subjective context leads to undertreated OSA.